3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Skin Carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Basal Cell
1
Interventions
Nivolumab
7
cemiplimab
6
Specimen Handling
5
HhAntag691
5
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
4
Biopsy
4
sonidegib
3
pembrolizumab
3
CTLA-4 Antigen
3
relatlimab
2
prednylidene
2
deltacortene
2
daromun
2
Surgical Procedures, Operative
2
Standard of Care
2
Prednisone
2
Observation
2
Aminolevulinic Acid
2
tocilizumab
1
talimogene laherparepvec
1
poly ICLC
1
flt3 ligand protein
1
X-Rays
1
Watchful Waiting
1
Vitamin D
1
Tomography, Optical Coherence
1
Therapeutics
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Basal Cell
×
Aftercare
×
1 year
×
Clear all
NCT07347392
2026-01-16
DOSCA-2
University of Aarhus
Enrolling by invitation
2,900 enrolled